Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02645487 · ClinicalTrials.gov registry record · NA
Stereotactic Radiosurgery (SRS) Dose-Escalation Study for Brain Metastasis
A NA study of Brain Neoplasms, Adult, Malignant, sponsored by University of Texas Southwestern Medical Center.
- Active
- Registry status
- NA
- Development phase
- 135
- Enrollment target
- 1
- Study location
NCT02645487 is a NA study of Brain Neoplasms, Adult, Malignant that is active but no longer recruiting, run by University of Texas Southwestern Medical Center. The registered enrollment target is 135 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02645487, a NA study of Brain Neoplasms, Adult, Malignant, is active but no longer recruiting, sponsored by University of Texas Southwestern Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 135 participants
- Enrollment target
- 1
- Study location
Study Summary
SRS dose escalation for brain metastases in radiation-naïve patients will establish true tolerable doses, which may exceed the current standard doses. This may lead to an improvement in local control, patient survival, and/or quality-of life.
Conditions Studied
Interventions
- RADIATION Stereotactic Radiosurgery
Study Locations (1)
Texas
- University of Texas Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 135 participants |
| Start Date | 2015-12-18 |
| Est. Completion | 2026-12-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02645487
The ClinicalTrials.gov registry entry for NCT02645487 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 135 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Brain Neoplasms, Adult, Malignant appearing as the primary indexed condition, and to 1 intervention - of which Stereotactic Radiosurgery is the first listed.
NCT02645487 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT02645487 about?
NCT02645487 is a clinical study titled "Stereotactic Radiosurgery (SRS) Dose-Escalation Study for Brain Metastasis". SRS dose escalation for brain metastases in radiation-naïve patients will establish true tolerable doses, which may exceed the current standard doses. This may lead to an improvement in local control, patient survival, and/or quality-of life.
What is the current status of trial NCT02645487?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 135 participants. The study started on 2015-12-18. Estimated completion is 2026-12-23.
What conditions does trial NCT02645487 study?
This clinical trial studies the following conditions: Brain Neoplasms, Adult, Malignant.
What interventions are being tested in trial NCT02645487?
The interventions under investigation include: Stereotactic Radiosurgery (RADIATION).
Who is sponsoring clinical trial NCT02645487?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02645487 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Neoplasms, Adult, Malignant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.